Navigation Links
Smith & Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA
Date:7/29/2009

ST. PETERSBURG, Fla., July 29 /PRNewswire-FirstCall/ -- Smith & Nephew Inc (NYSE: SNN) (LSE: SN) Advanced Wound Management division, announced the U.S. launch of ACTICOAT(TM) Flex 3 and ACTICOAT(TM) Flex 7, to expand the ACTICOAT portfolio. ACTICOAT Flex products have been designed to support physicians dealing with wounds and injuries at high risk of infection. Utilizing the unique Silcryst(R) nanocrystalline silver technology of ACTICOAT, the Flex line provides enhanced conformability on awkward anatomical areas such as face and hands and breakthrough stretch properties to improve patient comfort during wear. ACTICOAT Flex wound care products were recently cleared for market by the U.S. Food and Drug Administration.

Both ACTICOAT Flex 3 and ACTICOAT Flex 7 were cleared for use by Health Canada in late 2008. Dr. Sarvesh Logsetty, MD, FRCSC, FACS, Director of Manitoba Firefighters Burn Unit and Associate Professor, Plastic & General Surgery at the University of Manitoba commented on the product's excellent performance characteristics. "ACTICOAT Flex is a natural addition to the brand of dressings I trust when treating patients with wounds highly susceptible to infection. These dressings are preferable when treating wounds in areas of the body that require a high level of conformability, and when it is important to minimize trauma to the wound when removing the dressing," stated Dr. Logsetty. "The Flex dressing allows exudate to pass through, which is a great advantage," he explained.

"Combining the flexibility of the polyester mesh substrate with the proven effectiveness of ACTICOAT's nanocrystalline silver technology is an exciting and significant development for the ACTICOAT brand. The ACTICOAT Flex range of dressings is the result of listening to health care providers and underst
'/>"/>

SOURCE Smith & Nephew
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Hilary Smith Upped to Senior Vice President, Communications, NBC Universal Women & Lifestyle Entertainment Networks
2. UK Court of Appeal Rules in Smith & Nephews Favour
3. Upsher-Smith Laboratories, Inc. Updates Prenexa.com with Folic Acid Content, Money-Saving Coupon, and Personalized Address Labels
4. Mahindra Satyam Signs 5 Year SAP Contract with GlaxoSmithKline
5. H. D. Smith Promotes Leadership to Fill Two Senior Roles
6. GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare
7. GlaxoSmithKline Opens $600million Vaccine Plant In Singapore
8. GlaxoSmithKline Consumer Healthcare Makes Agency Changes to Support Growth on Global Brands
9. Smiths Donates $837,000 to Primary Childrens Medical Center in Utah
10. H. D. Smith Appoints Dave Watkins Chief Financial Officer
11. Leading Alzheimers Disease Researcher Mark A. Smith, PhD Named Scientific Advisor at Advana Science

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...Dec. 2 Reportlinker.com announces ...its catalogue: ,, Antibiotic Resistance and An...://www.reportlinker.com/p0166825/Antibiotic-Resist...ml ,, Provide an in-depth review of the global... technologies ,, Offer an analysis of antibioti...
(Date:12/2/2009)...2 ,, Statement by J...cts Association ,, In response to a new campa...(USADA) to educate consumers and rid the marketpla...y supplements, the Natural Products Association, t...ng retailers and manufacturers of dietary suppleme...
(Date:12/2/2009)...advanced cases, study finds , , WEDNESDA...des, survival rates for advanced lung cancer patie... new study has found. , Researchers analyzed da...age 4 non-small cell lung cancer (NSCLC) between 1....S. National Cancer Institute,s Surveillance, Epid...
(Date:12/2/2009)... of obesity could counter recent increases in long...ews) -- The overall health of the U.S. population ...because people have quit smoking in droves, but a ... out if the rising obesity rates among Americans d...both smoking and obesity continue unchanged, the a...
(Date:12/2/2009)... have metabolic syndrome, study finds , ,...lone isn,t enough to keep overweight college footb...l condition that can lead to heart disease, a new ...t Division I colleges and found that two-thirds we...ome, a group of conditions that raise the risk for...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 2Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 3Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 4Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 5Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 6Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 7Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 8Health News:Reportlinker Adds Antibiotic Resistance and Antibiotic Technologies: Global Markets 9Health News:Natural Products Association Issues Statement on New Supplement Safety Campaign 2Health News:Gains Made in Lung Cancer Survival 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:Oversized College Football Players May Face Heart Risks 2
...lp esophageal cancer patients also has been shown ...g to a research//. The study, using the anti-refl...ncreas or bile duct, appears in the May issue of G...ast year. The Dua stent, for short, has also been ...
...under the age of 65 who lacked health insurance fo....2 percent in 2005//. The proportion of uninsured ...e County to a high of 27.5 percent in Tyrrell Coun...ninsured lie east of Interstate 95. “County ...
...s toll and the number of injured soldiers is incre...e// lost their limbs. The Johns Hopkins Univer...unced that its team has developed a breakthrough p...to produce by 2009 a mechanical arm that closely m...
...portant to your health as the food itself. Researc...t might soon become// as important a risk factor f...fats. This class of toxins, called advanced...eeses. AGEs, which are also produced when food pro...
...epresentatives have looked at the growing need to ...will impact upon patients//, staff and managers ac...esearch focused on experiences and perceptions of ...icular healthcare contexts including patient infor...
...ity School of Medicine has helped confirm the reli...ach// individual's genetic makeup. The Stanf...termine that the genetic test can identify patient...e of expensive, debilitating drug therapy, while l...
Other Medicine News:Health News:Cancer Patient’s Life Improved With Anti-reflux Valv 2Health News:Cancer Patient’s Life Improved With Anti-reflux Valv 3Health News:Number of Uninsured in North Carolina on the Rise 2Health News:A Realistic Arm on the Anvil for Injured Soldiers 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 2Health News:Food Preparation may Play a Bigger Role in Chronic Disease 3Health News:Food Preparation may Play a Bigger Role in Chronic Disease 4Health News:New Test Helps Identify Hepatitis C Patients at High Risk of Developing Cirrhosis 2Health News:New Test Helps Identify Hepatitis C Patients at High Risk of Developing Cirrhosis 3
(Date:12/2/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, Pharmaceutical Contract Manufacturing - ...nker.com/p0164248/Pharmaceutical-Contract-Manufact...pharma industry faces numerous challenges in the f...rising cost of new product development, declining ...
(Date:12/2/2009)...wswire-USNewswire/ -- Jupiter Medical Center has...tools available into its imaging program, the new ...system delivers highly detailed images of the huma... unique applications, including dual breast scanni...with renal dysfunction. This results in shorter e...
(Date:12/2/2009)...-- With the addition of a Manhattan-based team of ...lairRyan,s medical malpractice defense practice ha...market. Mr. Ekblom, a former state prosecutor, has...-related malpractice claims. ,, The New York te...e defense attorneys located in LeClairRyan,s offic...
Breaking Medicine Technology:Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 2Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 3Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 4Reportlinker Adds Pharmaceutical Contract Manufacturing - Global Market Trends 5Jupiter Medical Center Announces New High-Definition MRI System 2Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 2Neil H. Ekblom and Medical Malpractice Defense Team Join LeClairRyan 3Shire Submits European Marketing Authorization Application 28MAA 29 for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 14957 1Shire Submits European Marketing Authorization Application 28MAA 29 for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 14957 2Shire Submits European Marketing Authorization Application 28MAA 29 for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 14957 3Genomic Health to Present at Piper Jaffray Health Care Conference 14955 1Genomic Health to Present at Piper Jaffray Health Care Conference 14955 2MAQUET Cardiovascular Receives Guaranteed Two Year Sole Source Contract From Novation for Beating Heart Surgical Devices 6503 1MAQUET Cardiovascular Receives Guaranteed Two Year Sole Source Contract From Novation for Beating Heart Surgical Devices 6503 2MAQUET Cardiovascular Receives Guaranteed Two Year Sole Source Contract From Novation for Beating Heart Surgical Devices 6503 3
...ould Benefit Millions Who Suffer From Condition, ... medicated, drug-eluting (dispensing), stents can ...al disease (PAD) is taking place at,Montefiore Med... joining in,the study. Medicated, drug-coated ste... several years in treating coronary artery disease...
.... 15 Knopp Neurosciences Inc. ("Knopp"),announced...ce of Orphan,Products Development has granted orph...t of amyotrophic lateral sclerosis (ALS). (Logo: ...PLOGO ) KNS-760704 is now completing Phase 1 stu...acokinetics of the compound in healthy human,subje...
Other Medicine Technology:Peripheral Arterial Disease to be Treated With New Medicated Stent in Trial at Montefiore 2Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS 2
Anti HTLV -I/HTLV -II
Trypanosoma Detect™ ELISA
Roche Accu-Chek Inform System
NexES® IHC
Medicine Products: